Shock. Shock : - Is inadequate organ perfusion - Is inadequate organ perfusion & tissue oxygenation...
-
Upload
graciela-angier -
Category
Documents
-
view
233 -
download
0
Transcript of Shock. Shock : - Is inadequate organ perfusion - Is inadequate organ perfusion & tissue oxygenation...
ShockShock: :
- - Is inadequate organ perfusionIs inadequate organ perfusion
& & tissue oxygenationtissue oxygenation
ShockShockClassificationClassification: :
A. HypovolemicA. Hypovolemic
depletion of vasualar voliumdepletion of vasualar volium
B. CardiogenicB. Cardiogenic
Intrinsic failure of the heartIntrinsic failure of the heart
C. Neurogenic ShockC. Neurogenic Shock
D. SepticD. Septic
Severe untreated sepsisSevere untreated sepsis
Causese of H.SCausese of H.S: .: .
- - BleedingBleeding
- - Protracted vomiting or diarrheaProtracted vomiting or diarrhea
- - Sequestration of fluid in gut lumenSequestration of fluid in gut lumen
- - Loss of plasma into injured tissuesLoss of plasma into injured tissues
( ( Burns / TraumaBurns / Trauma ) )
Compensatory mechanismCompensatory mechanism
Blood lossBlood loss
Initial vasoconstriction of cutaneusInitial vasoconstriction of cutaneus
- - muscle – visceramuscle – viscera
Preserve blood flow for kidneysPreserve blood flow for kidneys
- - Heart - BrainHeart - Brain
- - Normal blood volume is about %7 Normal blood volume is about %7 ofof
body weightbody weight
a 70 man # 5 Litrea 70 man # 5 Litre
Dx . Of Hypovolemic shockDx . Of Hypovolemic shock::
Goal isGoal is: :
Restore adequate tissue perfusionRestore adequate tissue perfusion..
resuscitation is similar traumatized patientresuscitation is similar traumatized patient::
- - Stablishing Air wayStablishing Air way
- - Stabilizing cervical spineStabilizing cervical spine
- - Dealing with ventilatory difficultiesDealing with ventilatory difficulties
- - Managing circulatory problemManaging circulatory problem
- - IV line – 16 G.cathaterIV line – 16 G.cathater
Dx of HVSDx of HVS::
11 . .Initial fluid resusitationInitial fluid resusitation: :
11 . .Ringer`s lactate orRinger`s lactate or
22 . .Normal salineNormal saline
DisadvantagesDisadvantages::
Hyperchloremic acidosis especially Hyperchloremic acidosis especially Impared renal function Impared renal function
- - Warming fluid for avoiding HypothermiaWarming fluid for avoiding Hypothermia
11 – – 22 L ImmediatelyL Immediately
Dx of HVS:Dx of HVS: ContCont……
22..CrystaloidsCrystaloids:: Mixture of sodium chloride & other Mixture of sodium chloride & other
Physiologically active solutes Physiologically active solutesمایع- مقدار کننده تعیین کریستالوئید مایع سدیم مایع- میزان مقدار کننده تعیین کریستالوئید مایع سدیم میزان
. بود خواهد .معرفی بود خواهد معرفیدر- عمدتا در- سدیم عمدتا %%8080و و Extra cellular SpaceExtra cellular SpaceسدیمExtra vascularExtra vascular. .است است
در- مایع تجمع سبب ها در- کریستالوئید مایع تجمع سبب ها Interstitial SpaceInterstitial Spaceکریستالوئیددر و شود در می و شود تقریبا Vascular SpaceVascular Spaceمی حدود و تقریبا کمتر حدود و % % 2020کمتر
. باشد .می باشد می
Dx of HVS :Dx of HVS : ContCont……
ها : کریستالوئید ها :عوارض کریستالوئید عوارض Hyperchloremic Metabolic acidosisHyperchloremic Metabolic acidosis
- - Drug interaction due toDrug interaction due to Calcium binding Ringer loctateCalcium binding Ringer loctate
“ “ Balanced Electrolyte solution contain NaBalanced Electrolyte solution contain Na , , Ca,KCa,K“ “
ContraindicationContraindication: : - - Dextrose – containing solutionDextrose – containing solution
( ( ischemia to organischemia to organ) )
Dx of HVS:Dx of HVS: ContCont……
33 . .ColloidsColloids: :
موئینه عروق دیواره از و دارد بزرگ موئینه ملکولهای عروق دیواره از و دارد بزرگ ملکولهای
را مایعات و کند می مثبت اسمزی فشار ایجاد و گذرد را نمی مایعات و کند می مثبت اسمزی فشار ایجاد و گذرد نمی
. از ناشی شوکهای در باالیی مصرف کشاند می عروق . بداخل از ناشی شوکهای در باالیی مصرف کشاند می عروق بداخل
دارد دارد هیپوولمی هیپوولمی
- - Human serum albuminHuman serum albumin
- - Hydroxyl ethyl starchHydroxyl ethyl starch
- - DextransDextrans
Dx of HVS:Dx of HVS: ContCont……
3-13-1 . .AlbuminAlbumin: : - - %80%80 of osmotic plasma pressureof osmotic plasma pressure
- - Carrier protein of Ca , MgCarrier protein of Ca , Mg.. - - AvailableAvailable: :
%5%5 ( ( 5050 g/lg/l ) ) or %25 (250 g/l )or %25 (250 g/l ) in isotonic salinein isotonic saline
- - Increase 5 time intravascular volumeIncrease 5 time intravascular volume - -DisadvDisadv: :
Allergic reactionAllergic reaction - - Half life 36 HsHalf life 36 Hs
Dx of HVS:Dx of HVS: ContCont……
3-23-2 . .HetastarchHetastarch: :
- - Synthetic Starch %6 ( 60 g/l )Synthetic Starch %6 ( 60 g/l )
in isotonic solutionin isotonic solution
- - Half life 24 / HHalf life 24 / H
- -DisadvantageDisadvantage ::
- - Hyper AmylasemiaHyper Amylasemia
- - AllergyAllergy
Dx of HVS:Dx of HVS: ContCont……
3-33-3 . .Dextran – 40Dextran – 40 - - Polysaccharide Sugar beetPolysaccharide Sugar beet
- - Expand intravascular volume twiceExpand intravascular volume twice - - Half life 6 HsHalf life 6 Hs
- -Dis advDis adv: : - - Bleeding risk inhibition of Bleeding risk inhibition of
platelet aggregation platelet aggregation - - AnaphylaxiaAnaphylaxia
- - Interference with crossmatchingInterference with crossmatching - - Acute renal failure Hypoosmolar stateAcute renal failure Hypoosmolar state
Dx of HVS:Dx of HVS: ContCont……
44 - - Hypertonic SalineHypertonic Saline: : %7.5%7.5 NaCl or ( 750 g/l )NaCl or ( 750 g/l )
Infusion RateInfusion Rate: : 44 mL / Kg / 2 minutesmL / Kg / 2 minutes
Maintain pressure 1 - 2 HsMaintain pressure 1 - 2 Hs AmountAmount: :
250250 mL infusionmL infusion Dis advDis adv: :
- - uncontrol Hemorrhageuncontrol Hemorrhage - - Systemic acidosisSystemic acidosis
Dx of HVS:Dx of HVS: ContCont……
55 – – Blood Component therapy ( BCT )Blood Component therapy ( BCT ) - - Fully crossmatched bloodFully crossmatched blood
time 1 hourtime 1 hour Specific or saline crossmatchedSpecific or saline crossmatched
time 10 minutestime 10 minutes - - ABO grouping - RhABO grouping - Rh
- - Whole bloodWhole blood Bag ( 450 ml ) with 50 ml AnticoagulantBag ( 450 ml ) with 50 ml Anticoagulant
preservative (citrate , dextrose , phosphate )preservative (citrate , dextrose , phosphate ) - - Stored 1 – 6 Stored 1 – 6 ̊c̊c
Dx of HVS:Dx of HVS: ContCont……
55 – – Blood component therapyBlood component therapy
- - Shelf life of whole blood 21 daysShelf life of whole blood 21 days
- - Packed cellsPacked cells
- - Blood warmer / pressurizedBlood warmer / pressurized
infusion ( 200 mmHg – 2 to 3 times )infusion ( 200 mmHg – 2 to 3 times )
- - Use wide – bore catheterUse wide – bore catheter
Note Warming blood reduces it Note Warming blood reduces it viscosityviscosity
Dx of HVS:Dx of HVS: ContCont……
66 – – Ultimate goal of DxUltimate goal of Dx: :
- - Normal blood pressureNormal blood pressure
Heart rateHeart rate
Urine outputUrine output